- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Implantable Neurostimulators market will register a 11.6% CAGR in terms of revenue, the global market size will reach $ 8176.8 million by 2025, from $ 5267.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Implantable Neurostimulators business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Neurostimulators market by type, application, key manufacturers and key regions and countries.
This study considers the Implantable Neurostimulators value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Parkinson's Disease
Epilepsy
Pain
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Inspire Medical
Boston Scientific
Cyberonics
NeuroPace
Abbott
ReShape Lifesciences
Synapse Biomedical
ElectroCore Medical
NeuroSigma
NEUROS
NEVRO
IMTHERA
SPR
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Implantable Neurostimulators consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Implantable Neurostimulators market by identifying its various subsegments.
Focuses on the key global Implantable Neurostimulators manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Implantable Neurostimulators with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Implantable Neurostimulators submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Implantable Neurostimulators Consumption 2015-2025
2.1.2 Implantable Neurostimulators Consumption CAGR by Region
2.2 Implantable Neurostimulators Segment by Type
2.2.1 Deep Brain Stimulators
2.2.2 Spinal Cord Stimulators
2.2.3 Vagal Nerve Stimulators
2.2.4 Sacral Nerve Stimulators
2.2.5 Gastric Stimulators
2.2.6 Others
2.3 Implantable Neurostimulators Consumption by Type
2.3.1 Global Implantable Neurostimulators Consumption Market Share by Type (2015-2020)
2.3.2 Global Implantable Neurostimulators Revenue and Market Share by Type (2015-2020)
2.3.3 Global Implantable Neurostimulators Sale Price by Type (2015-2020)
2.4 Implantable Neurostimulators Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Others
2.5 Implantable Neurostimulators Consumption by Application
2.5.1 Global Implantable Neurostimulators Consumption Market Share by Type (2015-2020)
2.5.2 Global Implantable Neurostimulators Value and Market Share by Type (2015-2020)
2.5.3 Global Implantable Neurostimulators Sale Price by Type (2015-2020)
3 Global Implantable Neurostimulators by Company
3.1 Global Implantable Neurostimulators Sales Market Share by Company
3.1.1 Global Implantable Neurostimulators Sales by Company (2018-2020)
3.1.2 Global Implantable Neurostimulators Sales Market Share by Company (2018-2020)
3.2 Global Implantable Neurostimulators Revenue Market Share by Company
3.2.1 Global Implantable Neurostimulators Revenue by Company (2018-2020)
3.2.2 Global Implantable Neurostimulators Revenue Market Share by Company (2018-2020)
3.3 Global Implantable Neurostimulators Sale Price by Company
3.4 Global Implantable Neurostimulators Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Implantable Neurostimulators Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Implantable Neurostimulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Implantable Neurostimulators by Regions
4.1 Implantable Neurostimulators by Regions
4.2 Americas Implantable Neurostimulators Consumption Growth
4.3 APAC Implantable Neurostimulators Consumption Growth
4.4 Europe Implantable Neurostimulators Consumption Growth
4.5 Middle East & Africa Implantable Neurostimulators Consumption Growth
5 Americas
5.1 Americas Implantable Neurostimulators Consumption by Countries
5.1.1 Americas Implantable Neurostimulators Consumption by Countries (2015-2020)
5.1.2 Americas Implantable Neurostimulators Value by Countries (2015-2020)
5.2 Americas Implantable Neurostimulators Consumption by Type
5.3 Americas Implantable Neurostimulators Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Implantable Neurostimulators Consumption by Regions
6.1.1 APAC Implantable Neurostimulators Consumption by Regions (2015-2020)
6.1.2 APAC Implantable Neurostimulators Value by Regions (2015-2020)
6.2 APAC Implantable Neurostimulators Consumption by Type
6.3 APAC Implantable Neurostimulators Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Implantable Neurostimulators by Countries
7.1.1 Europe Implantable Neurostimulators Consumption by Countries (2015-2020)
7.1.2 Europe Implantable Neurostimulators Value by Countries (2015-2020)
7.2 Europe Implantable Neurostimulators Consumption by Type
7.3 Europe Implantable Neurostimulators Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Implantable Neurostimulators by Countries
8.1.1 Middle East & Africa Implantable Neurostimulators Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Implantable Neurostimulators Value by Countries (2015-2020)
8.2 Middle East & Africa Implantable Neurostimulators Consumption by Type
8.3 Middle East & Africa Implantable Neurostimulators Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Implantable Neurostimulators Distributors
10.3 Implantable Neurostimulators Customer
11 Global Implantable Neurostimulators Market Forecast
11.1 Global Implantable Neurostimulators Consumption Forecast (2021-2025)
11.2 Global Implantable Neurostimulators Forecast by Regions
11.2.1 Global Implantable Neurostimulators Forecast by Regions (2021-2025)
11.2.2 Global Implantable Neurostimulators Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Implantable Neurostimulators Forecast by Type
11.8 Global Implantable Neurostimulators Forecast by Application
12 Key Players Analysis
12.1 Medtronic
12.1.1 Company Information
12.1.2 Implantable Neurostimulators Product Offered
12.1.3 Medtronic Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Inspire Medical
12.2.1 Company Information
12.2.2 Implantable Neurostimulators Product Offered
12.2.3 Inspire Medical Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Inspire Medical Latest Developments
12.3 Boston Scientific
12.3.1 Company Information
12.3.2 Implantable Neurostimulators Product Offered
12.3.3 Boston Scientific Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Boston Scientific Latest Developments
12.4 Cyberonics
12.4.1 Company Information
12.4.2 Implantable Neurostimulators Product Offered
12.4.3 Cyberonics Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Cyberonics Latest Developments
12.5 NeuroPace
12.5.1 Company Information
12.5.2 Implantable Neurostimulators Product Offered
12.5.3 NeuroPace Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 NeuroPace Latest Developments
12.6 Abbott
12.6.1 Company Information
12.6.2 Implantable Neurostimulators Product Offered
12.6.3 Abbott Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Abbott Latest Developments
12.7 ReShape Lifesciences
12.7.1 Company Information
12.7.2 Implantable Neurostimulators Product Offered
12.7.3 ReShape Lifesciences Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 ReShape Lifesciences Latest Developments
12.8 Synapse Biomedical
12.8.1 Company Information
12.8.2 Implantable Neurostimulators Product Offered
12.8.3 Synapse Biomedical Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Synapse Biomedical Latest Developments
12.9 ElectroCore Medical
12.9.1 Company Information
12.9.2 Implantable Neurostimulators Product Offered
12.9.3 ElectroCore Medical Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 ElectroCore Medical Latest Developments
12.10 NeuroSigma
12.10.1 Company Information
12.10.2 Implantable Neurostimulators Product Offered
12.10.3 NeuroSigma Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 NeuroSigma Latest Developments
12.11 NEUROS
12.11.1 Company Information
12.11.2 Implantable Neurostimulators Product Offered
12.11.3 NEUROS Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 NEUROS Latest Developments
12.12 NEVRO
12.12.1 Company Information
12.12.2 Implantable Neurostimulators Product Offered
12.12.3 NEVRO Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 NEVRO Latest Developments
12.13 IMTHERA
12.13.1 Company Information
12.13.2 Implantable Neurostimulators Product Offered
12.13.3 IMTHERA Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 IMTHERA Latest Developments
12.14 SPR
12.14.1 Company Information
12.14.2 Implantable Neurostimulators Product Offered
12.14.3 SPR Implantable Neurostimulators Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 SPR Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Implantable Neurostimulators Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
